康芝药业(300086.SZ)：止咳橘红颗粒药物临床试验获批准

Core Viewpoint - Kangzhi Pharmaceutical has received approval from the National Medical Products Administration for the clinical trial of "Cough Orange Granules" aimed at treating acute exacerbations of chronic obstructive pulmonary disease [1] Group 1 - The company announced the approval of the clinical trial for "Cough Orange Granules" [1] - The clinical trial will focus on patients with acute exacerbations of chronic obstructive pulmonary disease characterized by phlegm heat obstructing the lungs [1] - The company will further refine the clinical trial protocol before proceeding [1]